Dec 18 2009
Biovista Inc.
today announced the signing of a contract with Novus Biologicals for access
to Biovista's BEA literature mining platform. BEA will be used to power Novus
Explorer, a new service that Novus Biologicals is offering to visitors of its
web site. Driven by BEA, Novus Explorer will allow site visitors to identify
genes that are related to proteins, pathways and diseases of interest to
them, and from these browse Novus reagents that have been reported in the
literature to work well in experiments with those genes.
"We are very pleased that Novus selected our BEA platform to drive this
exciting new service," said Aris Persidis, Ph.D., President of Biovista. "The
flexibility of our BEA platform has allowed us to put together in a
relatively short amount of time this custom solution which meets Novus'
criteria for useful information provision coupled with specifics from Novus'
own line of products", Dr Persidis added.
"Novus is glad to have selected Biovista's proven technology to support a
service we hope will be of use to our site visitors and existing customers",
said Karen Padgett, CEO of Novus. "With Novus Explorer we aim to offer a free
service that will help researchers better understand their problem space and
at the same time enhance the user experience of our site visitors. Biovista's
BEA platform was a solution we found quite promising and we will be looking
forward to our visitors comments," Karen added.
SOURCE Biovista Inc.